97314 ⎘
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
High MAST2-affinity polypeptides and uses thereof
#2402Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same
#2403DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS
#2404Growth hormone fusion proteins with growth hormone receptor agonist activity
#2405Claudin-6-specific immunoreceptors and T cell epitopes
#2406Chimeric antigen receptor (CAR) signalling system
#2407Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer
#2408Compositions and methods for treating cancer
#2409MESENCHYMAL STEM CELLS FOR TARGETED CANCER THERAPY
#2410Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#2411NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE
#2412Artificial signal peptide
#2413Methods of Using Interleukin-10 for Treating Diseases and Disorders
#2414Lym-1 and Lym-2 targeted CAR cell immunotherapy
#2415Vaccine and therapeutic delivery system
#2416Compositions and methods for immunomodulation in an organism
#2417Algal based edible vaccines
#2418Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
#2419ANTI-NY-BR-1 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS
#2420Pseudotyped lentiviral vectors
#2421CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE
#2422Compositions and methods for immunomodulation in an organism
#2423Baculovirus display vectors and uses thereof
#2424Compositions and methods for targeting stromal cells for the treatment of cancer
#2425Recombinant obligate anaerobic gram-positive bacteria
#2426SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES
#2427DNA vaccine against virus of Yellow Fever
#2428PDK1 BINDING MOLECULES AND USES THEREOF
#2429Human mesothelin chimeric antigen receptors and uses thereof
#2430Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same
#2431PESTICIDAL FUSION PROTEIN IMPROVEMENTS
#2432Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
#2433Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria
#2434Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines
#2435Chimeric antigen receptors targeting B-cell maturation antigen
#2436Recombinant host cells and nucleic acid constructs encoding polypeptides having cellulolytic enhancing activity
#2437Cell
#2438Cell
#2439METHODS OF DIAGNOSING CANCER
#2440PHI-4 polypeptides and methods for their use
#2441ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE
#2442Nucleic acids for treatment of allergies
#2443Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
#2444Protease-resistant systems for polypeptide display and methods of making and using thereof
#2445PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN B IN PLANTS
#2446Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof
#2447Cells expressing apolipoprotein E and uses thereof
#2448Fusion proteins and combination vaccines comprising Protein E and Pilin A
#2449Long-acting coagulation factors and methods of producing same
#2450Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteins
#2451Fusion polypeptides comprising mucin-domain polypeptide linkers
#2452Composition comprising a mixture of CD95-Fc isoforms
#2453Epitope Spreading Associated with CAR T-Cells
#2454Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#2455CHIMERIC ANTIGEN RECEPTOR TARGETING OF TUMOR ENDOTHELIUM
#2456Methods and compositions for synthesizing improved silk fibers
#2457Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
#2458Compositions and methods for treatment of cancer
#2459Anti CD30 chimeric antigen receptor and its use
#2460Compositions and methods for treatment of cancer
#2461Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
#2462Phage displaying system expressing single chain antibody
#2463Antibodies to MUC16 and methods of use thereof
#2464Method of treating cancer with an EGFR targeted immunomodulatory fusion protein
#2465SIGNAL SEQUENCE FOR PROTEIN EXPRESSION IN PICHIA PASTORIS
#2466Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals
#2467Compositions and methods for treatment of cancer
#2468Methods for producing sialylated therapeutic proteins
#2469Targeted therapeutic proteins
#2470Methods and compositions for treating cancer
#2471Heat stable keratinase and use thereof
#2472Strong Secretory Signal Peptide Enhancing Small Peptide Motifs and the Use Thereof
#2473Compositions and methods for enhancing virus replication
#2474Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
#2475Compositions and methods for treatment of cancer
#2476Tumor tissue-penetrating peptide specific to neuropilin and fusion protein having same peptide fused therein
#2477Influenza virus-like particle production in plants
#2478Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses
#2479Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#2480-Prom mediated surface expression of avidin/streptavidin
#2481Surface display of functional proteins in a broad range of gram negative bacteria
#2482Vectors encoding rod-derived cone viability factor
#2483Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
#2484Anti-CD19 scFv (FMC63) polypeptide
#2485Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
#2486Compositions and methods for identifying enzyme and transport protein inhibitors
#2487Plant lectins as carriers of associated drug substances into animal and human cells
#2488Wnt antagonist and methods of treatment and screening
#2489Expression process
#2490CS1-specific chimeric antigen receptor engineered immune effector cells
#2491Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
#2492Coryneform bacterium and method for producing heterologous fusion proteins
#2493Improved Gene Targeting and Nucleic Acid Carrier Molecule, In Particular for Use in Plants
#2494Modified laminin containing collagen binding molecule and use thereof
#2495Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
#2496Treatment of cancer using a CLL-1 chimeric antigen receptor
#2497Strain secreting fatty acids by phospholipase and method for producing fatty acids using it
#2498Antibodies and methods for treating estrogen receptor-associated diseases
#2499Fusion polypeptides and vaccines
#2500Vaccine and therapeutic delivery system
#2501Vaccines for human papilloma virus and methods for using the same
#2502Thermostable β-xylosidase belonging to GH family 3
#2503Compositions and methods of use for treating metabolic disorders
#2504Cupredoxin derived transport agents and methods of use thereof
#2505Influenza nucleic acid molecules and vaccines made therefrom
#2506TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
#2507Delivery of card protein as therapy for occular inflammation
#2508Oligomers for TNF superfamily inhibition
#2509METHOD OF PRODUCING A PROTEIN
#2510Non-human animals having a humanized programmed cell death 1 gene
#2511Amyloid beta expression constructs and uses therefor
#2512Beta-hexosyl-transferases and uses thereof
#2513Endoglin polypeptides and uses thereof
#2514Vaccines against HPV
#2515Methods and compositions for modulating Toso activity
#2516METHODS AND COMPOSITIONS RELATING TO AMYLOIDOGENIC POLYPEPTIDES
#2517Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof
#2518BIOTINYLATED PROTEIN
#2519Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein
#2520Collagen-derived recombinant proteins with von Willebrand factor-binding activity
#2521Vaccine for treatment of tautopathy
#2522Recombinant novirhabdovirus usable as an antigen vector
#2523Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#2524Internalizing ErbB2 antibodies
#2525Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#2526Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer
#2527Nucleic acid vectors and uses thereof
#2528HYBRID PROTEINS AND USES THEREOF
#2529Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics
#2530Composition comprising a mixture of CD95-Fc isoforms and methods of producing same
#2531NOVEL FAR RED FLUORESCENT PROTEIN
#2532DEGRANULATION INDICATOR AND METHODS OF USE THEREOF
#2533Neurturin molecules
#2534Methods and compositions for modulating Toso activity
#2535Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#2536Intracellular protein delivery
#2537OX40L fusion protein for the immunotherapy of tumors of veterinary animals
#2538Peptide-hinge-free flexible antibody-like molecule
#2539Immunogenic compositions and methods of use thereof
#2540Fusion proteins and combination vaccines comprising Protein E and Pilin A
#2541Recombinant cellulosome complex and uses thereof
#2542Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof
#2543Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
#2544Fusion proteins and combination vaccines comprising Protein E and Pilin A
#2545Vaccines and methods for using the same
#2546Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#2547Surface anchored light chain bait antibody display system
#2548Long-acting polypeptides and methods of producing and administering same
#2549Neurturin molecules
#2550Anti-alpha-synuclein antibodies and methods of use
#2551Methods and compositions for modulating toso activity
#2552Compositions and methods for immunomodulation in an organism
#2553Chimeric receptors and uses thereof in immune therapy
#2554Wnt compositions and therapeutic uses of such compositions
#2555CHIMERIC PROTEINS FOR TREATMENT OF DISEASES
#2556Compositions and methods for Immunomodulation in an organism
#2557Spider silk fusion protein structures without repetitive fragment for binding to an organic target
#2558Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof
#2559Protein inhibitors to complement and VEGF pathways and methods of use thereof
#2560Fungal resistant plants expressing hydrophobin
#2561Chimeric peptides for the regulation of GTPases
#2562VACCINES AGAINST HPV
#2563DNA encoding canine monomeric CRP and expression vector containing the DNA
#2564Anti-mesothelin chimeric antigen receptors
#2565Muteins of αm lipocalin and method of production therefor
#2566Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#2567Modified leucine dehydrogenase
#2568Treating cardiovascular or renal diseases
#2569NPP1 fusion proteins
#2570Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same
#2571Methods and composition for secretion of heterologous polypeptides
#2572Expression process
#2573Use of the CD2 signaling domain in second-generation chimeric antigen receptors
#2574Modulators of MYC and methods of using the same
#2575Cells producing glycoproteins having altered glycosylation patterns and method and use thereof
#2576Bispecific antibody fragments for neurological disease proteins and methods of use
#2577Recombinant NEL-like (NELL) protein production
#2578Growth hormone receptor antagonists
#2579Expression vectors for cell-surface expression of polypeptides comprising a transmembrane domain of glycophorin A
#2580Aspartyl-tRNA synthetase-Fc conjugates
#2581Vectors encoding rod-derived cone viability factor
#2582Chimeric receptors with 4-1BB stimulatory signaling domain
#2583High MAST2-affinity polypeptides and uses thereof
#2584HBV polymerase mutants
#2585Polypeptides having immunoactivating activity and methods of producing the same
#2586Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2587VLPS containing ligands and methods related thereto
#2588Ligands modified by circular permutation as agonists and antagonists
#2589Method for secretory production of protein
#2590Mutant luciferases
#2591Protein comprising truncated form of extracellular region protein of Frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein
#2592Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
#2593mTOR ligands and polynucleotides encoding mTOR ligands
#2594Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#2595Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#2596Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof
#2597Methods for producing secreted polypeptides having biological activity
#2598Wnt compositions and therapeutic uses of such compositions
#2599SDF-1 delivery for treating ischemic tissue
#2600Modified laminin and use thereof
#2601Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
#2602Methods and compositions for cytomegalovirus IL-10 protein
#2603Antimicrobial peptides and uses thereof
#2604Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2605Protein complexes and methods of manufacturing bispecific antibodies using the protein complexes
#2606Methods for producing secreted polypeptides
#2607Fusion proteins and combination vaccines comprising Protein E and Pilin A
#2608Targeted therapeutic proteins
#2609OprF/I fusion proteins, their preparation and use
#2610Cupredoxin derived transport agents and methods of use thereof
#2611Vector particles for targeting CD34+ cells
#2612Expression and secretion system
#2613Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
#2614Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
#2615Xylanases, nucleic acids encoding them and methods for making and using them
#2616Internalizing erbB2 antibodies
#2617Fusion polypeptides comprising mucin-domain polypeptide linkers
#2618Ligands modified by circular permutation as agonists and antagonists
#2619Temperature-stable β-pyranosidase
#2620Peptides that modulate complex SASPase-FLG2
#2621Peptides for the specific binding of RNA targets
#2622Moesin fragments associated with immune thrombocytopenia
#2623SDF-1 delivery for treating ischemic tissue
#2624Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses
#2625Fibronectin based scaffold domain proteins that bind IL-23
#2626Use of chimeric antigen receptor-modified T-cells to treat cancer
#2627Systems for factor VIII processing and methods thereof
#2628Methods for increasing red blood cell levels comprising administering BMP9
#2629Methods and compositions for modulating Toso activity
#2630Interleukin 15 as selectable marker for gene transfer in lymphocytes
#2631NPP1 fusion proteins
#2632Covalently dimerized bivalent binding agents
#2633Molecular switches and methods for making and using the same
#2634Chimeric inhibitor molecules of complement activation
#2635Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains
#2636Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#2637Vaccine for treatment of tautopathy
#2638Antibodies to MUC16 and methods of use thereof
#2639Compositions and Methods for the Delivery of Biologically Active RNAs
#2640Protease screening methods and proteases identified thereby
#2641Isolation and application of BAD-1 for diagnosing infections with
#2642Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin
#2643Compositions, methods and uses for poxvirus elements in vaccine constructs
#2644Soluble tandem selectin glycoprotein ligand molecules
#2645Signal peptide, and use thereof for producing recombinant proteins
#2646Light-activated fusion proteins and uses therefor
#2647Biocatalysts and methods for the synthesis of ()-3-(1-aminoethyl)-phenol
#2648SOLUBLE EXPRESSION OF BULKY FOLDED ACTIVE PROTEINS
#2649Compositions and methods for increasing serum half-life
#2650Gene and polypeptide sequences
#2651METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY
#2652ENGINEERING CORRECTLY FOLDED ANTIBODIES USING INNER MEMBRANE DISPLAY OF TWIN-ARGININE TRANSLOCATION INTERMEDIATES
#2653TRANSIENT IMMORTALIZATION
#2654Wnt antagonists and methods of treatment and screening
#2655Polynucleotides encoding cyclotides having nematocidal activity
#2656Recombinant baculovirus vaccine
#2657Methods and compositions for enhanced expression and secretion of proteins
#2658Recombinant vaccines and use thereof
#2659Cupredoxin derived transport agents and methods of use thereof
#2660Activin-actriia antagonists and uses for treating multiple myeloma
#2661Chimeric peptides for the regulation of GTPases
#2662METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS
#2663Endoglucanases
#2664Reducing the immunogenicity of fusion proteins
#2665DNA vaccine against virus of yellow fever
#2666Protease screening methods and proteases identified thereby
#2667PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY
#2668Targeted therapeutic proteins
#2669Reporter vector presenting extracellular binding capacity to metallic compounds
#2670SDF-1 delivery for treating ischemic tissue
#2671SDF-1 delivery for treating ischemic tissue
#2672NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#2673SDF-1 DELIVERY FOR TREATING ISCHEMIC TISSUE
#2674Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein
#2675Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein
#2676NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IGE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME
#2677Constructs for expressing lysosomal polypeptides
#2678Method for binding a recombinant polypeptide to a carrier
#2679Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of DNA and chimeric virus vaccines
#2680Synthetic operon
#2681Prokaryotic expression construct
#2682Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
#2683Chimeric influenza virus-like particles comprising hemagglutinin
#2684Receptor activator of NF-kappaB
#2685Endoglucanases
#2686Method for treating cancer by administering IL-15 and IL-15Ralpha complexes
#2687Compositions and methods for identifying enzyme and transport protein inhibitors
#2688Use of SUC2 gene in for sucrose utilization
#2689Fibromodulin peptide
#2690INTERFERON-LIKE PROTEINS AND USES THEREOF
#2691Methods for synthesizing sugar chains using β1,3-N-acetylglucosaminyltransferase
#2692Protein expression system
#2693Targeted therapeutic proteins
#2694METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#2695Methods for producing secreted polypeptides
#2696Proteins
#2697VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS
#2698Truncated somatostatin receptors
#2699HCV vaccines and methods for using the same
#2700Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens